G. Trinchieri, Biology of natural killer cells, Adv Immunol, vol.47, pp.60664-60665, 1989.

C. A. Biron, K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-mather, Natural killer cells in antiviral defense: function and regulation by innate cytokines, Annu Rev Immunol, vol.17, pp.189-220, 1999.

M. J. Robertson and J. Ritz, Biology and clinical relevance of human natural killer cells, Blood, vol.76, pp.2421-2438, 1990.

M. A. Cooper, T. A. Fehniger, and M. A. Caligiuri, The biology of human natural killer-cell subsets, Trends Immunol, vol.22, pp.633-640, 2001.

M. J. Wilson, M. Torkar, A. Haude, S. Milne, T. Jones et al., Plasticity in the organization and sequences of human KIR/ILT gene families, Proc Natl Acad Sci U S A, vol.97, pp.4778-4783, 2000.

J. Trowsdale, D. C. Jones, A. D. Barrow, and J. A. Traherne, Surveillance of cell and tissue perturbation by receptors in the LRC, Immunol Rev, vol.267, pp.117-136, 2015.

S. Kim, J. Poursine-laurent, S. M. Truscott, L. Lybarger, Y. J. Song et al., Licensing of natural killer cells by host major histocompatibility complex class I molecules, Nature, vol.436, pp.709-713, 2005.

N. Anfossi, P. Andre, S. Guia, C. S. Falk, S. Roetynck et al., Human NK cell education by inhibitory receptors for MHC class I, Immunity, vol.25, pp.331-342, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00165596

J. Yu, G. Heller, J. Chewning, S. Kim, W. M. Yokoyama et al., Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands, J Immunol, vol.179, pp.5977-5989, 2007.

N. Tarek, L. Luduec, J. B. Gallagher, M. M. Zheng, J. Venstrom et al., Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment, J Clin Invest, vol.122, pp.3260-3270, 2012.

M. T. Orr, W. J. Murphy, and L. L. Lanier, Unlicensed' natural killer cells dominate the response to cytomegalovirus infection, Nat Immunol, vol.11, pp.321-327, 2010.

N. C. Fernandez, E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux et al., A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules, Blood, vol.105, pp.4416-4423, 2005.

H. G. Hilton, L. A. Guethlein, A. Goyos, N. Nemat-gorgani, D. A. Bushnell et al., Polymorphic HLA-C receptors balance the functional characteristics of KIR haplotypes, J Immunol, vol.195, pp.3160-3170, 2015.

A. K. Moesta, P. J. Norman, M. Yawata, N. Yawata, M. Gleimer et al., Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3, J Immunol, vol.180, pp.3969-3979, 2008.

W. H. Carr, M. J. Pando, and P. Parham, KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand, J Immunol, vol.175, pp.5222-5229, 2005.

M. Yawata, N. Yawata, M. Draghi, A. M. Little, F. Partheniou et al., Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function, J Exp Med, vol.203, pp.633-645, 2006.

M. Colonna, G. Borsellino, M. Falco, G. B. Ferrara, and J. L. Strominger, HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1-and NK2-specific natural killer cells, Proc Natl Acad Sci U S A, vol.90, pp.12000-12004, 1993.

C. C. Winter, J. E. Gumperz, P. Parham, E. O. Long, and N. Wagtmann, Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition, J Immunol, vol.161, pp.571-577, 1998.

A. K. Moesta, T. Graef, L. Abi-rached, O. Aguilar, A. M. Guethlein et al., Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I, J Immunol, vol.185, pp.4233-4237, 2010.

M. Uhrberg, P. Parham, and P. Wernet, Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes, Immunogenetics, vol.54, pp.221-229, 2002.

M. Uhrberg, N. M. Valiante, B. P. Shum, H. G. Shilling, K. Lienert-weidenbach et al., Human diversity in killer cell inhibitory receptor genes, Immunity, vol.7, pp.80394-80399, 1997.

M. Cella, A. Longo, G. B. Ferrara, J. L. Strominger, and M. Colonna, NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80, J Exp Med, vol.180, pp.1235-1242, 1994.

J. E. Gumperz, V. Litwin, J. H. Phillips, L. L. Lanier, and P. Parham, The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor, J Exp Med, vol.181, pp.1133-1144, 1995.

M. Stern, L. Ruggeri, M. Capanni, A. Mancusi, and A. Velardi, Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1, Blood, vol.112, pp.708-710, 2008.

A. M. Wan, P. Ennis, P. Parham, and N. Holmes, The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes, J Immunol, vol.137, pp.3671-3674, 1986.

J. E. Boudreau, T. J. Mulrooney, L. Luduec, J. B. Barker, E. Hsu et al., KIR3DL1 and HLA-B density and binding calibrate NK education and response to HIV, J Immunol, vol.196, pp.3398-3410, 2016.

G. M. O'connor, K. J. Guinan, R. T. Cunningham, D. Middleton, P. Parham et al., Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells, J Immunol, vol.178, pp.235-241, 2007.

G. M. O'connor, J. P. Vivian, J. M. Widjaja, J. S. Bridgeman, E. Gostick et al., Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity, J Immunol, vol.192, pp.2875-2884, 2014.

A. Trundley, H. Frebel, D. Jones, C. Chang, and J. Trowsdale, Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies, Eur J Immunol, vol.37, pp.780-787, 2007.

C. M. Gardiner, L. A. Guethlein, H. G. Shilling, M. Pando, W. H. Carr et al., Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism, J Immunol, vol.166, pp.2992-3001, 2001.

J. E. Boudreau, L. Luduec, J. B. Hsu, and K. C. , Development of a novel multiplex PCR assay to detect functional subtypes of KIR3DL1 alleles, PLoS One, vol.9, 2014.

M. P. Martin, Y. Qi, X. Gao, E. Yamada, J. N. Martin et al., Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1, Nat Genet, vol.39, pp.733-740, 2007.

S. Boulet, M. Kleyman, J. Y. Kim, P. Kamya, S. Sharafi et al., A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection, AIDS, vol.22, pp.1487-1491, 2008.

M. Yawata, N. Yawata, M. Draghi, F. Partheniou, A. M. Little et al., MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing selfresponse, Blood, vol.112, pp.2369-2380, 2008.

P. Kamya, S. Boulet, C. M. Tsoukas, J. P. Routy, R. Thomas et al., Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57, J Virol, vol.85, pp.5949-5960, 2011.

P. Kamya, B. Tallon, C. Melendez-pena, M. S. Parsons, S. A. Migueles et al., Inhibitory killer immunoglobulin-like receptors to self HLA-B and HLA-C ligands contribute differentially to natural killer cell functional potential in HIV infected slow progressors, Clin Immunol, vol.143, pp.246-255, 2012.

R. Song, I. Lisovsky, B. Lebouche, J. P. Routy, J. Bruneau et al., HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets, PLoS Pathog, vol.10, 2014.

S. Boulet, R. Song, P. Kamya, J. Bruneau, N. H. Shoukry et al., HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells, J Immunol, vol.184, pp.2057-2064, 2010.

G. B. Cohen, R. T. Gandhi, D. M. Davis, O. Mandelboim, B. K. Chen et al., The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells, Immunity, vol.10, pp.80065-80070, 1999.

M. I. Bonaparte and E. Barker, Killing of human immunodeficiency virusinfected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules, Blood, vol.104, pp.2087-2094, 2004.

R. Apps, D. Prete, G. Q. Chatterjee, P. Lara, A. Brumme et al., HIV-1 Vpu mediates HLA-C downregulation, Cell Host Microbe, vol.19, pp.686-695, 2016.

Z. Ende, M. J. Deymier, D. T. Claiborne, J. L. Prince, D. C. Monaco et al., HLA class I downregulation by HIV-1 variants from subtype C transmission pairs, J Virol, vol.92, pp.1633-1650, 2018.

C. Korner, C. R. Simoneau, P. Schommers, M. Granoff, M. Ziegler et al., HIV-1-mediated downmodulation of HLA-C impacts target cell recognition and antiviral activity of NK cells, Cell Host Microbe, vol.22, pp.111-119, 2017.

O. Schwartz, V. Marechal, L. Gall, S. Lemonnier, F. Heard et al., Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein, Nat Med, vol.2, pp.338-342, 1996.

A. Specht, A. Telenti, R. Martinez, J. Fellay, E. Bailes et al., Counteraction of HLA-Cmediated immune control of HIV-1 by Nef, J Virol, vol.84, pp.7300-7311, 2010.

N. D. Bachtel, G. Umviligihozo, S. Pickering, T. M. Mota, H. Liang et al., HLA-C downregulation by HIV-1 adapts to host HLA genotype, PLoS Pathog, vol.14, 2018.

H. G. Hilton, L. Vago, O. Aguilar, A. M. Moesta, A. K. Graef et al., Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3, J Immunol, vol.189, pp.1418-1430, 2012.

P. Brodin, T. Lakshmikanth, S. Johansson, K. Karre, and P. Hoglund, The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells, Blood, vol.113, pp.2434-2441, 2009.

A. K. Moesta and P. Parham, Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3, Front Immunol, vol.3, p.336, 2012.

G. Alter, D. Heckerman, A. Schneidewind, L. Fadda, C. M. Kadie et al., HIV-1 adaptation to NK-cell-mediated immune pressure, Nature, vol.476, pp.96-100, 2011.

H. G. Hilton and P. Parham, Missing or altered self: human NK cell receptors that recognize HLA-C, Immunogenetics, vol.69, pp.567-579, 2017.

V. Beziat, L. L. Liu, J. A. Malmberg, M. A. Ivarsson, E. Sohlberg et al., NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs, Blood, vol.121, pp.2678-2688, 2013.

G. David, Z. Djaoud, C. Willem, N. Legrand, P. Rettman et al., Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 specificity of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation, J Immunol, vol.191, pp.4778-4788, 2013.

G. David, M. Morvan, K. Gagne, N. Kerdudou, C. Willem et al., Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies, Immunology, vol.128, pp.172-184, 2009.

M. Carrington and G. Alter, Innate immune control of HIV. Cold Spring Harb Perspect Med 2:a007070, 2012.

A. Habegger-de-sorrentino, J. L. Sinchi, K. Marinic, R. López, and E. Iliovich, KIR-HLA-A and B alleles of the Bw4 epitope against HIV infection in discordant heterosexual couples in Chaco Argentina, Immunology, vol.140, pp.273-279, 2013.

G. Alter, M. P. Martin, N. Teigen, W. H. Carr, T. J. Suscovich et al., Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes, J Exp Med, vol.204, pp.3027-3036, 2007.

G. Alter, N. Teigen, R. Ahern, H. Streeck, A. Meier et al., Evolution of innate and adaptive effector cell functions during acute HIV-1 infection, J Infect Dis, vol.195, pp.1452-1460, 2007.

A. T. Haase, Early events in sexual transmission of HIV and SIV and opportunities for interventions, Annu Rev Med, vol.62, pp.127-139, 2011.

S. V. Shah, C. Manickam, D. R. Ram, K. Kroll, H. Itell et al., CMV primes functional alternative signaling in adaptive ?g NK cells but is subverted by lentivirus infection in rhesus macaques, Cell Rep, vol.25, pp.2766-2774, 2018.

I. Lisovsky, S. Kant, A. Tremblay-mclean, G. Isitman, Z. Kiani et al., Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC, J Leukoc Biol, vol.105, pp.551-563, 2019.

A. Oliva, A. L. Kinter, M. Vaccarezza, A. Rubbert, A. Catanzaro et al., Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro, J Clin Invest, vol.102, pp.223-231, 1998.

W. C. Nelson, C. W. Pyo, D. Vogan, R. Wang, Y. S. Pyon et al., An integrated genotyping approach for HLA and other complex genetic systems, Hum Immunol, vol.76, pp.928-938, 2015.

P. Hansasuta, T. Dong, H. Thananchai, M. Weekes, C. Willberg et al., Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific, Eur J Immunol, vol.34, pp.1673-1679, 2004.